Literature DB >> 16939497

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

Daniel Primo1, Juan Flores, Sandra Quijano, María Luz Sanchez, María Eugenia Sarasquete, Javier del Pino-Montes, Per Ivar Gaarder, Marcos Gonzalez, Alberto Orfao.   

Abstract

Despite the effects of BCR ABL on cell proliferation, no study has compared the proliferative rate of different haematopoietic cell compartments from chronic myeloid leukaemia (CML) with those of normal bone marrow (NBM). We comparatively analysed the cell cycle distribution and BCR/ABL expression in different compartments of BM cells from 15 CML and 11 NBM. Overall, our results showed similar proliferative indices in CML patients and NBM. However, CD34+ myeloid precursors from CML patients displayed an increased proportion of S + G2/M-phase cells (P = 0.04), while no significant differences were found between CML and NBM for other BM cell subsets analysed. In BM cells separated by fluorescence-activated cell sorting, decreasing levels of BCR/ABL mRNA were found from CD34+/CD38+ myeloid precursors to myeloblasts; BCR/ABL expression increased afterwards with a peak at the myelocyte/metamyelocyte stage, decreasing in the more mature band/neutrophil compartment. Unexpectedly, BCR/ABL gene expression showed an inverse correlation with the proportion of S + G2/M-phase cells (R = -0.33; P = 0.04). These results suggest that in CML, BCR/ABL expression is associated with an increased proliferation of CD34+ myeloid haematopoietic progenitor cells but not of other more mature myeloid precursors, as confirmed by the observation of an inverse correlation between the amount of BCR/ABL transcripts and the proportion of S + G2/M-phase cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16939497     DOI: 10.1111/j.1365-2141.2006.06265.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

1.  Bcl2 is not required for the development and maintenance of leukemia stem cells in mice.

Authors:  Inés González-Herrero; Carolina Vicente-Dueñas; Alberto Orfao; Teresa Flores; Rafael Jiménez; César Cobaleda; Isidro Sánchez-García
Journal:  Carcinogenesis       Date:  2010-03-18       Impact factor: 4.944

2.  Cell Regulation of Proliferation and Differentiation ex vivo for Cells Containing Ph Chromosome in Chronic Myeloid Leukemia.

Authors:  N I Grineva; T V Akhlynina; L P Gerasimova; T E Manakova; N G Sarycheva; D A Schmarov; A M Tumofeev; N M Nydenova; L Yu Kolosova; T I Kolosheynova; L G Kovaleva; S V Kuznetsov; A V Vorontsova; A G Turkina
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

3.  Gene Expression upon Proliferation and Differentiation of Hematopoietic Cells with Ph Chromosome ex vivo.

Authors:  N I Grineva; E A Duchovenskay; A M Timofeev; T V Akhlynina; L P Gerasimova; T V Borovkova; D A Schmarov; N G Sarycheva; N M Naydenova; A R Gavrichkova; L Y Kolosova; T I Kolosheynova; L G Kovaleva
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

4.  The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.

Authors:  Sergio Matarraz; Cristina Teodosio; Carlos Fernandez; Manuel Albors; María Jara-Acevedo; Antonio López; María Gonzalez-Gonzalez; María Laura Gutierrez; Juan Flores-Montero; Carlos Cerveró; Marlies Pizarro-Perea; María Paz Garrastazul; Gonzalo Caballero; Oliver Gutierrez; Guy Daniel Mendez; Manuel González-Silva; Paula Laranjeira; Alberto Orfao
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

5.  Cancer induction by restriction of oncogene expression to the stem cell compartment.

Authors:  María Pérez-Caro; César Cobaleda; Inés González-Herrero; Carolina Vicente-Dueñas; Camino Bermejo-Rodríguez; Margarita Sánchez-Beato; Alberto Orfao; Belén Pintado; Teresa Flores; Manuel Sánchez-Martín; Rafael Jiménez; Miguel A Piris; Isidro Sánchez-García
Journal:  EMBO J       Date:  2008-11-27       Impact factor: 11.598

Review 6.  Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.

Authors:  M Mimeault; R Hauke; P P Mehta; S K Batra
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

7.  Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.

Authors:  Elen Oliveira; Thiago S Bacelar; Juana Ciudad; Maria Cecília M Ribeiro; Daniela R N Garcia; Lukasz Sedek; Simone F Maia; Daniel B Aranha; Indyara C Machado; Arissa Ikeda; Bianca F Baglioli; Nathalia Lopez-Duarte; Lisandra A C Teixeira; Tomasz Szczepanski; Maria Luiza M Silva; Marcelo G P Land; Alberto Orfao; Elaine S Costa
Journal:  Oncotarget       Date:  2016-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.